logo
episode-header-image
Sep 2024
17m 59s

Episode 347: ESMO 2024 - DV + Pembro in ...

THE UROMIGOS
About this episode

Matt Galsky describes his ESMO 2024 abstract of disitimab vedotiin + pembrlizumab in bladder cancer

Up next
Jul 7
Episode 430: Structured Exercise Improves DFS/OS after Adjuvant Therapy in Colorectal Cancer - Does This Apply to GU Cancers?
Chris Booth joins the show to discuss his recent NEJM paper that demonstrated significant DFS and OS improvements with a structured exercise program after adjuvant chemo in colorectal cancer. We discuss implications for GU and other malignancies. 
45m 46s
Jul 2
Episode 429: ASCO2025レポート
ASCO2025の注目演題を取り上げ解説、ディスカッションしました! 
42m 47s
Jun 16
Episode 428: ASCO 2025 Recap
Brian, Tom and Silke discuss their highlights form ASCO 2025 
54m 20s
Recommended Episodes
Sep 2024
ESMO 2024 GU Update
We are doing a special episode this week to cover some of the key GU abstracts from ESMO 2024. We cover an update on the STAMPEDE prostate cancer trial, SUNNIFORECAST in non-clear cell renal cell carcinoma, SunRISe-4 in bladder cancer, and more. 
18m 10s
Apr 29
BOSS update: Oesophageal cancer with Massimiliano Di Pietro (bonus episode)
Hot off the press: The BOSS (Barrett’s Oesophagus Surveillance Versus Endoscopy at Need Study) randomised control study. Is surveillance really not affecting survival in oesophageal cancer patients? To put things into perspective, we asked Massimiliano Di Pietro, UEG Talks podcas ... Show More
22m 45s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Apr 2022
Bladder Cancer
Today’s episode is focusing on bladder cancer - what you need to know about the pathology, presentation, diagnostic work-up, staging, treatment, and rarer upper GU tract presentations. 
13m 56s
Jul 2024
807 | Fran Drescher: "95% Of Cancers Is Environmentally Caused."
Actress, comedian, writer, and activist Fran Drescher makes her first appearance on the show to talk about how a cancer diagnosis transformed her life and what she's done because of it. Source: Fran Drescher: Pain into Purpose Connect with Fran Drescher:  Instagram: officialf ... Show More
15m 51s
Aug 2024
A Reassessment of Prostate Cancer Treatment (Live from the 2024 ASCO Annual Meeting)
About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Join Lauren Bright Pacheco at the 2024 ASCO Annual Meeting in Chicago, as she investigates the advancements in prostate cancer care.  Dr. Mohammad Atiq shares ways innovative treatments are paving the ... Show More
41m 41s
Jan 2024
Dr. Srikala Sridhar talks about PET imaging on staging of MIBC
In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Dr. Srikala Sridhar (CA), about her abstract she recently presented at ESMO 2023, PET-MUSE: “Impact of positron emission tomography (PET) imaging on staging of muscle-invasive bladder cancer (MIBC)”. D ... Show More
7m 43s
Dec 2024
Non-Muscle Invasive Bladder Cancer Basics with Dr. Kyle Richards
Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More
12m 52s
Mar 2024
Colon Cancer Treatment with Hardeep Phull, MD
March is colon cancer awareness month so in today's episode, I discuss oncologic treatment options for colorectal cancer with Dr. Hardeep Phull. Dr. Phull is Medical Director of Oncology at Palomar Health and Clinical Instructor at the University of California San Diego. He ... Show More
25m 11s
Jul 2024
Why are young people getting colon cancer? | Dr. Andy Chan
Rates of colorectal cancer have declined in people over 65 but doubled among people under 50 in the last few decades. By 2030 it’s expected to be the leading cancer-related death in this age group. In today’s episode, gastrointestinal cancer and prevention specialist, Dr. Andy Ch ... Show More
1h 5m